id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1207659174504620037,1207659174504620037,2019-12-19 19:19:19 IST,2019-12-19,19:19:19,+0530,14886375,stocktwits,Stocktwits,,"Stocktwits Trending Tickers BMO 12/19/19    $NKE Earnings AMC.   $EXEL Exelixis teams up with Roche for cancer treatment.   $MU Analyst upgrades after yesterday‚Äôs ER beat.   $RAD +27% pre-market, ER beat BMO.   $CAG +7% pre-market, ER beat BMO.     et al.",en,[],[],[],0,3,9,[],"['nke', 'exel', 'mu', 'rad', 'cag']",https://twitter.com/Stocktwits/status/1207659174504620037,False,,0,,,,,,,,[],,,,
1207632261673357312,1207632261673357312,2019-12-19 17:32:22 IST,2019-12-19,17:32:22,+0530,206746746,exelixisinc,Exelixis,,"$EXEL enters clinical collaboration with @Roche for three phase 3 combination trials for patients with advanced #kidneycancer, #lungcancer and #prostatecancer. Details here:  https://t.co/JJL1n6wV9e.  https://t.co/YJNRShz1eZ",en,"[{'screen_name': 'roche', 'name': 'roche', 'id': '20815041'}]",['https://bit.ly/35De753'],['https://pbs.twimg.com/media/EMJfI8qWsAUuk2e.jpg'],1,3,7,"['kidneycancer', 'lungcancer', 'prostatecancer']",['exel'],https://twitter.com/ExelixisInc/status/1207632261673357312,False,,1,https://pbs.twimg.com/media/EMJfI8qWsAUuk2e.jpg,,,,,,,[],,,,
1167486728132845569,1167486728132845569,2019-08-30 22:48:21 IST,2019-08-30,22:48:21,+0530,14115408,jonnajarian,Jon Najarian,"{'type': 'Point', 'coordinates': [44.75975, 20.50673]}",üï∞Ô∏è60 Seconds: Caf√© de casa ‚òïÔ∏è $MU is back Sept 47 calls. $CX Jan 2021 calls. $EXEL Oct 22 calls.   Have a great long weekend see you in Vegas üé≤ Oct 4th &amp; 5th  https://t.co/tBEgDGkUfM @petenajarian @ Coffee Casa  https://t.co/ey6YkmrQYE,en,"[{'screen_name': 'petenajarian', 'name': 'pete najarian', 'id': '14292717'}]","['http://investitute.com/Vegas', 'https://www.instagram.com/p/B1y9K9UDRaa/?igshid=1x414ogd216rk']",[],0,3,8,[],"['mu', 'cx', 'exel']",https://twitter.com/jonnajarian/status/1167486728132845569,False,,0,,,,,,,,[],,,,
1167485185643962368,1167485185643962368,2019-08-30 22:42:13 IST,2019-08-30,22:42:13,+0530,14115408,jonnajarian,Jon Najarian,,üï∞Ô∏è60 Seconds: Caf√© de casa ‚òïÔ∏è $MU is back Sept 47 calls. $CX Jan 2021 calls. $EXEL Oct 22 calls.   Have a great long weekend see you in Vegas üé≤ Oct 4th &amp; 5th  https://t.co/AK4fGys2B7  https://t.co/A2YpkXyq0R,en,[],['http://www.investitute.com/Vegas'],[],3,4,27,[],"['mu', 'cx', 'exel']",https://twitter.com/jonnajarian/status/1167485185643962368,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1167485116651843584/pu/img/lk-qK0Qu6RiG6sFJ.jpg,,,,,,,[],,,,
1155540171229728769,1155540171229728769,2019-07-28 23:37:00 IST,2019-07-28,23:37:00,+0530,274233761,bradloncar,Brad Loncar,,Big week of earnings ahead.  M: $ILMN $NBIX $SNY T: $AMGN $GILD $INCY $MRK $PFE W: $ACAD $AMRN $EXEL $VRTX T: $BPMC $CLVS $IOVA $VKTX F: $IMGN  Full list here:  https://t.co/rkVR6KO4b7  https://t.co/fM7N4kAQLg,en,[],['https://www.loncarblog.com/july-29-earnings'],['https://pbs.twimg.com/media/EAgoy8DUYAAqfOB.jpg'],0,18,40,[],"['ilmn', 'nbix', 'sny', 'amgn', 'gild', 'incy', 'mrk', 'pfe', 'acad', 'amrn', 'exel', 'vrtx', 'bpmc', 'clvs', 'iova', 'vktx', 'imgn']",https://twitter.com/bradloncar/status/1155540171229728769,False,,1,https://pbs.twimg.com/media/EAgoy8DUYAAqfOB.jpg,,,,,,,[],,,,
1144028971769589760,1144028971769589760,2019-06-27 05:15:36 IST,2019-06-27,05:15:36,+0530,274233761,bradloncar,Brad Loncar,,$EXEL ad in the SSF BART station.  https://t.co/ENWXZPUGQl,en,[],[],['https://pbs.twimg.com/media/D-BoR9zUcAEVco6.jpg'],6,0,12,[],['exel'],https://twitter.com/bradloncar/status/1144028971769589760,False,,1,https://pbs.twimg.com/media/D-BoR9zUcAEVco6.jpg,,,,,,,[],,,,
1142058108505776128,1142058108505776128,2019-06-21 18:44:06 IST,2019-06-21,18:44:06,+0530,873399943,jacobplieth,Jacob Plieth,,$EXEL off 6% on melanoma failure for MEK+Tecentriq vs Keytruda in BRAF w/t patients. One of the dumbest trials ever? $RHHBY,en,[],[],[],6,3,9,[],"['exel', 'rhhby']",https://twitter.com/JacobPlieth/status/1142058108505776128,False,,0,,,,,,,,[],,,,
1095429546336239620,1095429546336239620,2019-02-13 02:38:50 IST,2019-02-13,02:38:50,+0530,206746746,exelixisinc,Exelixis,,We are excited to announce the initiation of phase 1 clinical development for our first $EXEL-discovered compound since opening our new labs in Alameda last summer. For more info:  https://t.co/GK0NPvOvAs.  https://t.co/Q1ZeznZn8K,en,[],['https://bit.ly/2E5UKpM'],['https://pbs.twimg.com/media/DzO_VVPUwAAZXpI.jpg'],0,4,10,[],['exel'],https://twitter.com/ExelixisInc/status/1095429546336239620,False,,1,https://pbs.twimg.com/media/DzO_VVPUwAAZXpI.jpg,,,,,,,[],,,,
1095080504490115072,1095079547765248001,2019-02-12 03:31:52 IST,2019-02-12,03:31:52,+0530,873399943,jacobplieth,Jacob Plieth,,"Keynote-426 OS, PFS, ORR &amp; safety, via Thomas Powles #GU19 $MRK $BMY $PFE $EXEL  https://t.co/AFkPYiqNl1",de,[],[],"['https://pbs.twimg.com/media/DzKBvFdWwAEIAIX.jpg', 'https://pbs.twimg.com/media/DzKBvzMXQAEgv1U.jpg', 'https://pbs.twimg.com/media/DzKBwgxXgAE7QsI.jpg', 'https://pbs.twimg.com/media/DzKBxcFXgAArqeM.jpg']",1,17,31,['gu19'],"['mrk', 'bmy', 'pfe', 'exel']",https://twitter.com/JacobPlieth/status/1095080504490115072,False,,1,https://pbs.twimg.com/media/DzKBvFdWwAEIAIX.jpg,,,,,,,[],,,,
1095079547765248001,1095079547765248001,2019-02-12 03:28:04 IST,2019-02-12,03:28:04,+0530,873399943,jacobplieth,Jacob Plieth,,$MRK blasts $BMY out of the water... again. This time in renal cancer. My take on KN-426 data at ASCO #GU19 $EXEL $PFE  https://t.co/2bQycfXPma,en,[],['http://www.evaluate.com/vantage/articles/news/trial-results/asco-gu-bristols-renal-cancer-lead-looks-be-short-lived'],[],11,26,54,['gu19'],"['mrk', 'bmy', 'exel', 'pfe']",https://twitter.com/JacobPlieth/status/1095079547765248001,False,,0,,,,,,,,[],,,,
1094679897648386050,1094679897648386050,2019-02-11 01:00:00 IST,2019-02-11,01:00:00,+0530,274233761,bradloncar,Brad Loncar,,Healthcare earnings this week.  M: $BRKR T: $EXEL $KMDA W: $IRWD $TEVA $VNDA T: $AGIO $ALKS $AZN $INCY F: $CPSI  The full schedule:  https://t.co/KhK0QR1dUN  https://t.co/NmkbogSV7f,en,[],['https://www.loncarblog.com/february-11-earnings'],['https://pbs.twimg.com/media/DzBDCnQWkAAnR02.jpg'],4,5,11,[],"['brkr', 'exel', 'kmda', 'irwd', 'teva', 'vnda', 'agio', 'alks', 'azn', 'incy', 'cpsi']",https://twitter.com/bradloncar/status/1094679897648386050,False,,1,https://pbs.twimg.com/media/DzBDCnQWkAAnR02.jpg,,,,,,,[],,,,
1056648297333514240,1056648297333514240,2018-10-29 02:16:00 IST,2018-10-29,02:16:00,+0530,274233761,bradloncar,Brad Loncar,,The earnings week ahead:  M: $GNMK $VCYT T: $AMGN $CLVS $EXAS $PFE W: $ACOR $GSK  $ICPT $SNY T: $AGIO $AMRN $EXEL $PBYI F: $ABBV $PETX $CBPO  Full list:  https://t.co/0pMct4grFg  https://t.co/Fsr1Y3jn49,en,[],['https://www.loncarblog.com/october-29-earnings'],['https://pbs.twimg.com/media/DqlO9q3VYAAY0m_.jpg'],1,7,17,[],"['gnmk', 'vcyt', 'amgn', 'clvs', 'exas', 'pfe', 'acor', 'gsk', 'icpt', 'sny', 'agio', 'amrn', 'exel', 'pbyi', 'abbv', 'petx', 'cbpo']",https://twitter.com/bradloncar/status/1056648297333514240,False,,1,https://pbs.twimg.com/media/DqlO9q3VYAAY0m_.jpg,,,,,,,[],,,,
1054017577540898816,1054017577540898816,2018-10-21 20:02:27 IST,2018-10-21,20:02:27,+0530,873399943,jacobplieth,Jacob Plieth,,"What does $PFE Javelin Renal 101 mean for $EXEL &amp; $BMY? And what about $MRK? Today's late-breaker from #ESMO18, via @Vantageanalysis  https://t.co/C1asurOSJj",en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://www.evaluate.com/vantage/articles/events/conferences/esmo-2018-front-line-kidney-showdown-now-features-four-players'],[],1,10,8,['esmo18'],"['pfe', 'exel', 'bmy', 'mrk']",https://twitter.com/JacobPlieth/status/1054017577540898816,False,,0,,,,,,,,[],,,,
1052892151372292096,1052892151372292096,2018-10-18 17:30:25 IST,2018-10-18,17:30:25,+0530,873399943,jacobplieth,Jacob Plieth,,Good point - $PFE owns Inlyta $MRK $LKGAF $BMY $EXEL,en,[],[],[],0,0,5,[],"['pfe', 'mrk', 'lkgaf', 'bmy', 'exel']",https://twitter.com/JacobPlieth/status/1052892151372292096,False,https://twitter.com/bradloncar/status/1052891739055316997,0,,,,,,,,[],,,,
1039535059643113473,1039535059643113473,2018-09-11 20:54:06 IST,2018-09-11,20:54:06,+0530,873399943,jacobplieth,Jacob Plieth,,"$EXEL screwed first (unfairly) by $BMY CM-214, and now (more fairly) by $PFE Javelin Renal 101?",en,[],[],[],3,2,6,[],"['exel', 'bmy', 'pfe']",https://twitter.com/JacobPlieth/status/1039535059643113473,False,https://twitter.com/zbiotech/status/1039534675088293888,0,,,,,,,,[],,,,
1023617398899965953,1023617398899965953,2018-07-29 22:43:00 IST,2018-07-29,22:43:00,+0530,274233761,bradloncar,Brad Loncar,,Another huge week of earnings coming up. A link to the full schedule is below.  M: $ILMN T: $INCY $PFE $SNY $SHPG W: $CLVS $EXAS $EXEL $UTHR T: $ICPT $REGN $TSRO $TEVA F: $GLPS $PETX  Full schedule:  https://t.co/kBnNAJ4Nqn  https://t.co/jxYkTOakey,en,[],['http://www.loncarblog.com/july-30-earnings'],['https://pbs.twimg.com/media/DjOlOcDU8AAo077.jpg'],4,17,32,[],"['ilmn', 'incy', 'pfe', 'sny', 'shpg', 'clvs', 'exas', 'exel', 'uthr', 'icpt', 'regn', 'tsro', 'teva', 'glps', 'petx']",https://twitter.com/bradloncar/status/1023617398899965953,False,,1,https://pbs.twimg.com/media/DjOlOcDU8AAo077.jpg,,,,,,,[],,,,
994468099360518144,994468099360518144,2018-05-10 12:14:05 IST,2018-05-10,12:14:05,+0530,873399943,jacobplieth,Jacob Plieth,,Imblaze-370 fails. $EXEL $RHHBY Here‚Äôs why that shouldn‚Äôt entirely have come as a surprise  https://t.co/kLLAO16kWT,en,[],['http://www.epvantage.com/Universal/View.aspx?type=Story&id=778674&isEPVantage=yes'],[],3,10,26,[],"['exel', 'rhhby']",https://twitter.com/JacobPlieth/status/994468099360518144,False,,0,,,,,,,,[],,,,
994443365449117697,994443365449117697,2018-05-10 10:35:48 IST,2018-05-10,10:35:48,+0530,274233761,bradloncar,Brad Loncar,,Tecentriq and Cotellic didn't succeed in heavily pretreated advanced CRC. Roche is suggesting it's because almost all patients were micro satellite stable. $EXEL  https://t.co/TPDB1e3Dcr,en,[],['https://twitter.com/genentech/status/994442636764336136'],[],1,6,16,[],['exel'],https://twitter.com/bradloncar/status/994443365449117697,False,https://twitter.com/genentech/status/994442636764336136,0,,,,,,,,[],,,,
990655202318577664,990655202318577664,2018-04-29 23:43:00 IST,2018-04-29,23:43:00,+0530,274233761,bradloncar,Brad Loncar,,Huge week of earnings coming up.  M: $AGN $NBIX T: $GILD $INCY $IRWD $MRK W: $EXEL $NVO $UTHR T: $ALNY $REGN $SAGE $SRPT F: $AGIO $CELG $IONS  The full list:  https://t.co/iMjW2l3E9A  https://t.co/fa6YYIzhOy,en,[],['http://www.loncarblog.com/april-30-earnings'],['https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg'],1,20,42,[],"['agn', 'nbix', 'gild', 'incy', 'irwd', 'mrk', 'exel', 'nvo', 'uthr', 'alny', 'regn', 'sage', 'srpt', 'agio', 'celg', 'ions']",https://twitter.com/bradloncar/status/990655202318577664,False,,1,https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg,,,,,,,[],,,,
968231643315089409,968231643315089409,2018-02-27 02:39:47 IST,2018-02-27,02:39:47,+0530,274233761,bradloncar,Brad Loncar,,$EXEL Cabo franchise revenue.  https://t.co/f3iCBYu3BG  https://t.co/g2tUr9Rr59,es,[],['http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-news&nyo=0'],['https://pbs.twimg.com/media/DW_ZikxVQAAeNjH.jpg'],2,4,9,[],['exel'],https://twitter.com/bradloncar/status/968231643315089409,False,,1,https://pbs.twimg.com/media/DW_ZikxVQAAeNjH.jpg,,,,,,,[],,,,
968100978888183808,968100978888183808,2018-02-26 18:00:34 IST,2018-02-26,18:00:34,+0530,14886375,stocktwits,Stocktwits,,Here's who reports earnings this week. Get ready  Mon - $FIT $EXEL $PANW $CLVS Tue - $SQ $PCLN $M $WTW $FTR $LL $HTZ $ALB $WDAY Wed - $VRX $DDD $CRM $VALE $BOX $LOW $MYL $LB $SSYS Thu - $F $AMBA $SRPT $BBY $SPLK $GPS Fri - $GOGO $FL $EFX $WUBA    https://t.co/BrJnctSA18,en,[],['https://stocktwits.com/discover/earnings-calendar'],[],2,21,38,[],"['fit', 'exel', 'panw', 'clvs', 'sq', 'pcln', 'm', 'wtw', 'ftr', 'll', 'htz', 'alb', 'wday', 'vrx', 'ddd', 'crm', 'vale', 'box', 'low', 'myl', 'lb', 'ssys', 'f', 'amba', 'srpt', 'bby', 'splk', 'gps', 'gogo', 'fl', 'efx', 'wuba']",https://twitter.com/Stocktwits/status/968100978888183808,False,,0,,,,,,,,[],,,,
967839866317713408,967839866317713408,2018-02-26 00:43:00 IST,2018-02-26,00:43:00,+0530,274233761,bradloncar,Brad Loncar,,This week's earnings calendar:  M: $CLVS $EXEL T: $ACAD $FGEN $TSRO W: $HZNP $MYL $VRX T: $NKTR $PBYI $SRPT  Full schedule:  https://t.co/Ecf1Po8wvT  https://t.co/O2qRMw1TI8,en,[],['http://www.loncarblog.com/february-26-earnings'],['https://pbs.twimg.com/media/DW1LOyZUMAASYcl.jpg'],3,14,43,[],"['clvs', 'exel', 'acad', 'fgen', 'tsro', 'hznp', 'myl', 'vrx', 'nktr', 'pbyi', 'srpt']",https://twitter.com/bradloncar/status/967839866317713408,False,,1,https://pbs.twimg.com/media/DW1LOyZUMAASYcl.jpg,,,,,,,[],,,,
960877184629071875,960644433506168832,2018-02-06 19:35:47 IST,2018-02-06,19:35:47,+0530,873399943,jacobplieth,Jacob Plieth,,Quite the discrepancy in Immotion-151 between investigator-assessed and independently reviewed PFS $RHHBY $BMY $EXEL $PFE  https://t.co/SNdXX5ALqw,en,[],[],['https://pbs.twimg.com/media/DVW4oueWAAAc2QU.jpg'],3,12,23,[],"['rhhby', 'bmy', 'exel', 'pfe']",https://twitter.com/JacobPlieth/status/960877184629071875,False,,1,https://pbs.twimg.com/media/DVW4oueWAAAc2QU.jpg,,,,,,,[],,,,
949703174855671808,949701702357196800,2018-01-06 23:34:16 IST,2018-01-06,23:34:16,+0530,47678782,megtirrell,Meg Tirrell,,@bradloncar Ah there it is. I noticed an $EXEL billboard on the ride into the city but not a ton else (though it was dark),en,[],[],[],0,0,6,[],['exel'],https://twitter.com/megtirrell/status/949703174855671808,False,,0,,,,,,,,"[{'screen_name': 'bradloncar', 'name': 'Brad Loncar', 'id': '274233761'}]",,,,
925819014806491136,925819014806491136,2017-11-02 01:47:08 IST,2017-11-02,01:47:08,+0530,274233761,bradloncar,Brad Loncar,,"Speaking of amazing. $EXEL has earnings. Like a real PE ratio.  Net Income of $81.4M, Diluted EPS of $0.26/share.    https://t.co/gN07F5U7P1",en,[],['http://www.businesswire.com/news/home/20171101006786/en/Exelixis-Announces-Quarter-2017-Financial-Results-Corporate'],[],3,12,21,[],['exel'],https://twitter.com/bradloncar/status/925819014806491136,False,,0,,,,,,,,[],,,,
919923800560545794,919923800560545794,2017-10-16 19:21:40 IST,2017-10-16,19:21:40,+0530,873399943,jacobplieth,Jacob Plieth,,"Meet $EXEL, biotech's comeback kid. Via @EPVantage  https://t.co/2H6XBzlgGD",en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://epvantage.com/Universal/View.aspx?type=Story&id=739091&isEPVantage=yes'],[],1,10,12,[],['exel'],https://twitter.com/JacobPlieth/status/919923800560545794,False,,0,,,,,,,,[],,,,
919914237409013761,919914237409013761,2017-10-16 18:43:40 IST,2017-10-16,18:43:40,+0530,15971805,investorslive,Nathan Michaud,,$EXEL $TRXC $TGTX nice ranger so far,fr,[],[],[],0,0,11,[],"['exel', 'trxc', 'tgtx']",https://twitter.com/InvestorsLive/status/919914237409013761,False,,0,,,,,,,,[],,,,
919898095378452480,919898095378452480,2017-10-16 17:39:31 IST,2017-10-16,17:39:31,+0530,56413858,foxbusiness,FOX Business,,"Exelixis liver cancer drug meets late-stage goal, shares jump $EXEL  https://t.co/AJ0OKuURvu",en,[],['http://fxn.ws/2ifs7ya'],[],0,5,10,[],['exel'],https://twitter.com/FoxBusiness/status/919898095378452480,False,,0,,,,,,,,[],,,,
913773431384084480,913773431384084480,2017-09-29 20:02:17 IST,2017-09-29,20:02:17,+0530,47678782,megtirrell,Meg Tirrell,,"In today's drug price increase news, $EXEL ups kidney cancer drug Cabometyx by 5%, per @CowenResearch  https://t.co/gMSEMcL88a",en,"[{'screen_name': 'cowenresearch', 'name': 'cowenresearch', 'id': '701464597'}]",[],['https://pbs.twimg.com/media/DK5gFEsU8AE8tEy.jpg'],2,4,7,[],['exel'],https://twitter.com/megtirrell/status/913773431384084480,False,,1,https://pbs.twimg.com/media/DK5gFEsU8AE8tEy.jpg,,,,,,,[],,,,
912120814186696704,912120814186696704,2017-09-25 06:35:23 IST,2017-09-25,06:35:23,+0530,274233761,bradloncar,Brad Loncar,,Filed under the category of things I didn't know. $EXEL has a hypertension program with Daiichi Sankyo.,en,[],[],[],3,1,14,[],['exel'],https://twitter.com/bradloncar/status/912120814186696704,False,,0,,,,,,,,[],,,,
910518587621875712,910518587621875712,2017-09-20 20:28:42 IST,2017-09-20,20:28:42,+0530,873399943,jacobplieth,Jacob Plieth,,Questions that still need answering after #ESMO17 Checkmate-214 debacle $BMY $EXEL Via @RobinDavison2  https://t.co/K7mxHABt6P,en,"[{'screen_name': 'robindavison2', 'name': 'robin davison', 'id': '402719725'}]",['http://epvantage.com/Universal/View.aspx?type=Story&id=733069&isEPVantage=yes'],[],1,1,11,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/910518587621875712,False,,0,,,,,,,,[],,,,
908704855090515969,908704855090515969,2017-09-15 20:21:35 IST,2017-09-15,20:21:35,+0530,873399943,jacobplieth,Jacob Plieth,,The biggest story of #ESMO17? I reckon this medical non-disclosure mystery is up there. Via @EPVantage  https://t.co/pd540onI8V $BMY $EXEL,en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://epvantage.com/Universal/View.aspx?type=Story&id=731938&isEPVantage=yes'],[],1,12,22,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/908704855090515969,False,,0,,,,,,,,[],,,,
907204836978040834,907204006392582144,2017-09-11 17:01:02 IST,2017-09-11,17:01:02,+0530,873399943,jacobplieth,Jacob Plieth,,A renal cancer mystery as $BMY clashes with $EXEL #ESMO17  https://t.co/i6657AC5KA,en,[],['http://epvantage.com/Universal/View.aspx?type=Story&id=730531&isEPVantage=yes'],[],1,5,6,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/907204836978040834,False,,0,,,,,,,,[],,,,
906829169006448640,906771776205619200,2017-09-10 16:08:16 IST,2017-09-10,16:08:16,+0530,873399943,jacobplieth,Jacob Plieth,,"B Escudier: ""I suspect $BMY and $EXEL will both get approval (1L renal), and I suspect nivo+ipi will become standard of care"" #ESMO17",en,[],[],[],1,7,7,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/906829169006448640,False,,0,,,,,,,,[],,,,
906771968627802112,906771776205619200,2017-09-10 12:20:58 IST,2017-09-10,12:20:58,+0530,873399943,jacobplieth,Jacob Plieth,,Bernard Escudier Checkmate-214 safety &amp; conclusions $BMY #ESMO17 $EXEL  https://t.co/eWlZJG4ptq,en,[],[],"['https://pbs.twimg.com/media/DJWASeqXkAAeObC.jpg', 'https://pbs.twimg.com/media/DJWASeuWsAIWa6W.jpg']",2,10,12,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/906771968627802112,False,,1,https://pbs.twimg.com/media/DJWASeqXkAAeObC.jpg,,,,,,,[],,,,
906771776205619200,906771776205619200,2017-09-10 12:20:13 IST,2017-09-10,12:20:13,+0530,873399943,jacobplieth,Jacob Plieth,,Bernard Escudier Checkmate-214 Opdivo + Yervoy in renal $BMY #ESMO17 $EXEL  https://t.co/2ZZfbU2Prt,es,[],[],"['https://pbs.twimg.com/media/DJWAHVuXkAAhKNI.jpg', 'https://pbs.twimg.com/media/DJWAHVtW0AI6pIF.jpg', 'https://pbs.twimg.com/media/DJWAHVvXgAAol0C.jpg']",2,24,28,['esmo17'],"['bmy', 'exel']",https://twitter.com/JacobPlieth/status/906771776205619200,False,,1,https://pbs.twimg.com/media/DJWAHVuXkAAhKNI.jpg,,,,,,,[],,,,
903236259740573697,903236259740573697,2017-08-31 18:11:20 IST,2017-08-31,18:11:20,+0530,701464597,cowenresearch,cowenresearch,,"CowenBiotech writes on #ESMO 2017 abstracts and $ARRY, $BGNE, $BPMC, $CASC, $CRIS, $EXEL, $IMDC, $IMMU, $INCY, $MGNX, $STML, $SYRS, $TSRO",en,[],[],[],0,2,5,['esmo'],"['arry', 'bgne', 'bpmc', 'casc', 'cris', 'exel', 'imdc', 'immu', 'incy', 'mgnx', 'stml', 'syrs', 'tsro']",https://twitter.com/CowenResearch/status/903236259740573697,False,,0,,,,,,,,[],,,,
897777722075873281,897777722075873281,2017-08-16 16:41:03 IST,2017-08-16,16:41:03,+0530,102754598,johncendpts,John Carroll,,Bristol-Myers shares sink after another setback for its immuno-oncology franchise drugs $BMY -3.5% $EXEL +3.5%  https://t.co/VPv41PKUcI,en,[],['https://endpts.com/bristol-myers-shares-sink-after-another-setback-for-its-immuno-oncology-franchise-drugs/'],[],2,9,8,[],"['bmy', 'exel']",https://twitter.com/JohnCendpts/status/897777722075873281,False,,0,,,,,,,,[],,,,
891750251786190848,891750251786190848,2017-07-31 01:30:02 IST,2017-07-31,01:30:02,+0530,274233761,bradloncar,Brad Loncar,,155 calls this week  M: $SNY $ZIOP T: $ILMN $INCY $PFE W: $BMRN $CLVS $EXEL T: $JUNO $REGN $TEVA F: $PETX  All here:  https://t.co/x7luehKPDU  https://t.co/qVxoREIrn6,en,[],['http://www.loncarblog.com/july-31-healthcare-earnings'],['https://pbs.twimg.com/media/DF7oYFQUIAAsU7-.jpg'],9,13,30,[],"['sny', 'ziop', 'ilmn', 'incy', 'pfe', 'bmrn', 'clvs', 'exel', 'juno', 'regn', 'teva', 'petx']",https://twitter.com/bradloncar/status/891750251786190848,False,,1,https://pbs.twimg.com/media/DF7oYFQUIAAsU7-.jpg,,,,,,,[],,,,
883114619136593920,883114619136593920,2017-07-07 05:35:07 IST,2017-07-07,05:35:07,+0530,15568127,themotleyfool,The Motley Fool,,"Soon as a midcap biotech starts turning a profit, it starts turning the heads of  would-be buyers. $EXEL $ICPT $PTLA  https://t.co/AiRSKUpsN9",en,[],['https://www.fool.com/investing/2017/07/05/3-mid-cap-biotech-stocks-that-may-be-red-hot-takeo.aspx'],[],0,7,18,[],"['exel', 'icpt', 'ptla']",https://twitter.com/themotleyfool/status/883114619136593920,False,,0,,,,,,,,[],,,,
859138800362168326,859138800362168326,2017-05-02 01:43:46 IST,2017-05-02,01:43:46,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$EXEL reported its first profitable quarter based on operations. That‚Äôs a milestone.,en,[],[],[],4,13,29,[],['exel'],https://twitter.com/adamfeuerstein/status/859138800362168326,False,,0,,,,,,,,[],,,,
859137137354178560,859137137354178560,2017-05-02 01:37:10 IST,2017-05-02,01:37:10,+0530,274233761,bradloncar,Brad Loncar,,$EXEL was profitable last quater. What a long road. Congrats to them.,en,[],[],[],2,8,23,[],['exel'],https://twitter.com/bradloncar/status/859137137354178560,False,,0,,,,,,,,[],,,,
858747786313035776,858747786313035776,2017-04-30 23:50:01 IST,2017-04-30,23:50:01,+0530,274233761,bradloncar,Brad Loncar,,155 calls this week  M: $EXEL $ZIOP T: $GILD $MRK $PFE W: $BPMC $CLVS $NVO T: $BMRN $INCY $REGN F: $ALNY  Full list:  https://t.co/e22IcW00lr  https://t.co/A15cDBl2zM,en,[],['http://www.loncarblog.com/may-1-healthcare-earnings'],['https://pbs.twimg.com/media/C-m5HvaUAAAaBgU.jpg'],9,21,52,[],"['exel', 'ziop', 'gild', 'mrk', 'pfe', 'bpmc', 'clvs', 'nvo', 'bmrn', 'incy', 'regn', 'alny']",https://twitter.com/bradloncar/status/858747786313035776,False,,1,https://pbs.twimg.com/media/C-m5HvaUAAAaBgU.jpg,,,,,,,[],,,,
849716657845153793,849716657845153793,2017-04-06 01:43:32 IST,2017-04-06,01:43:32,+0530,274233761,bradloncar,Brad Loncar,,Over the last week we've seen one biotech pay down debt and another return some money to shareholders. Two rare headlines. $EXEL $MACK  https://t.co/7ldSGz3Pj9,en,[],[],"['https://pbs.twimg.com/media/C8rMyt1VoAAB0az.jpg', 'https://pbs.twimg.com/media/C8rMyt1V0AAil_C.jpg']",2,1,9,[],"['exel', 'mack']",https://twitter.com/bradloncar/status/849716657845153793,False,,1,https://pbs.twimg.com/media/C8rMyt1VoAAB0az.jpg,,,,,,,[],,,,
830778492249858050,830778492249858050,2017-02-12 19:30:02 IST,2017-02-12,19:30:02,+0530,11247222,timothysykes,Timothy Sykes,, https://t.co/Bh3ZJG5m2v - Posted a New Webinar: Challenge Webinar 2-9 [On Demand] $AEHR $EXEL,de,[],['https://profit.ly/500CTI'],[],0,0,13,[],"['aehr', 'exel']",https://twitter.com/timothysykes/status/830778492249858050,False,,0,,,,,,,,[],,,,
814912976780165120,814912976780165120,2016-12-31 00:46:08 IST,2016-12-31,00:46:08,+0530,274233761,bradloncar,Brad Loncar,,Five big biotech winners in 2016:  $CRBP +420% $CLCD +340% $AVXS +170% $EXEL +160% $TSRO +160%  https://t.co/hUmktMTdWb,nl,[],[],['https://pbs.twimg.com/tweet_video_thumb/C08mcFzVEAE1Lv6.jpg'],12,22,37,[],"['crbp', 'clcd', 'avxs', 'exel', 'tsro']",https://twitter.com/bradloncar/status/814912976780165120,False,,1,https://pbs.twimg.com/tweet_video_thumb/C08mcFzVEAE1Lv6.jpg,,,,,,,[],,,,
810859105808224260,810859105808224260,2016-12-19 20:17:30 IST,2016-12-19,20:17:30,+0530,47348249,michael_gilman,Michael Gilman,,Nice to see Mike Morrissey of $EXEL on this list. Chalk one up for R&amp;D guys succeeding in the commercial world!  https://t.co/kQCQpM6Vgn,en,[],['https://www.thestreet.com/story/13930531/1/the-best-biopharma-ceos-of-2016-are.html'],[],0,1,8,[],['exel'],https://twitter.com/michael_gilman/status/810859105808224260,False,,0,,,,,,,,[],,,,
810850457925062656,810850457925062656,2016-12-19 19:43:08 IST,2016-12-19,19:43:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The Best Biopharma CEOs of 2016 are‚Ä¶ ‚Äî&gt;  https://t.co/rmvHsHI6UP  $MRK Frazier $MDVN Hung $CPXX Jackson $SRPT Kaye $EXEL Morrissey,en,[],['https://www.thestreet.com/story/13930531/1/the-best-biopharma-ceos-of-2016-are.html'],[],8,31,57,[],"['mrk', 'mdvn', 'cpxx', 'srpt', 'exel']",https://twitter.com/adamfeuerstein/status/810850457925062656,False,,0,,,,,,,,[],,,,
809214479649165312,809214479649165312,2016-12-15 07:22:21 IST,2016-12-15,07:22:21,+0530,201891203,sanglucci,SangLucci‚Ñ¢,,"Open house 2morrow, ALL tools on in Lounge(free).   https://t.co/4h1n819HuS  SWEEPERBRIEFS - 12/14/16 $CDZI $ADP $C $EXEL $RIG $ON $TSLA $SPY  https://t.co/tJtU57vqsh",en,[],['http://bit.ly/2e1LIyR'],"['https://pbs.twimg.com/media/Czrl9lIUAAAj5n1.jpg', 'https://pbs.twimg.com/media/Czrl9lLUUAARe8C.jpg', 'https://pbs.twimg.com/media/Czrl9lKUQAADAGF.jpg']",0,5,7,[],"['cdzi', 'adp', 'c', 'exel', 'rig', 'on', 'tsla', 'spy']",https://twitter.com/sanglucci/status/809214479649165312,False,,1,https://pbs.twimg.com/media/Czrl9lIUAAAj5n1.jpg,,,,,,,[],,,,
794149790145773568,794149790145773568,2016-11-03 17:40:39 IST,2016-11-03,17:40:39,+0530,47678782,megtirrell,Meg Tirrell,,Initiations by DB per Street Account $ALXN $BMRN $EXEL $HALO $NBIX $PRTA $ARIA  https://t.co/1vPJXDIPDF,en,[],[],['https://pbs.twimg.com/media/CwVjBOrWIAApPzZ.jpg'],0,7,10,[],"['alxn', 'bmrn', 'exel', 'halo', 'nbix', 'prta', 'aria']",https://twitter.com/megtirrell/status/794149790145773568,False,,1,https://pbs.twimg.com/media/CwVjBOrWIAApPzZ.jpg,,,,,,,[],,,,
768821413658648576,768821413658648576,2016-08-25 20:14:43 IST,2016-08-25,20:14:43,+0530,873399943,jacobplieth,Jacob Plieth,,Leerink #ESMO16 preview: Keynote024 $MRK Checkmate026 $BMY Nova $TSRO l-breakers; Ariel2 $CLVS $EXEL $INCY $IPH IO combos $ARIA $KITE $ADAP,en,[],[],[],4,5,7,['esmo16'],"['mrk', 'bmy', 'tsro', 'clvs', 'exel', 'incy', 'iph', 'aria', 'kite', 'adap']",https://twitter.com/JacobPlieth/status/768821413658648576,False,,0,,,,,,,,[],,,,
768431897156448256,768431897156448256,2016-08-24 18:26:55 IST,2016-08-24,18:26:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"We (the royal) give biotech cos. shit for taking on convertible debt, so must also credit those cos. which pay it off.   $EXEL today.",en,[],[],[],1,9,28,[],['exel'],https://twitter.com/adamfeuerstein/status/768431897156448256,False,,0,,,,,,,,[],,,,
760931340430737410,760931340430737410,2016-08-04 01:42:23 IST,2016-08-04,01:42:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$EXEL Cabometyx Q2 net sales $17.6M. That seems strong but admittedly, I don‚Äôt know what was expected.",en,[],[],[],0,0,9,[],['exel'],https://twitter.com/adamfeuerstein/status/760931340430737410,False,,0,,,,,,,,[],,,,
759786548309000192,759786548309000192,2016-07-31 21:53:23 IST,2016-07-31,21:53:23,+0530,274233761,bradloncar,Brad Loncar,,Only 171 calls this week.  M: $KERX T: $PFE $SHPG W: $EXEL $ZTS T: $ACAD $AGIO $REGN F: $PETX  The full list:  https://t.co/iPfghquBni,en,[],['http://loncarblog.com/aug1-earnings.html'],[],5,12,30,[],"['kerx', 'pfe', 'shpg', 'exel', 'zts', 'acad', 'agio', 'regn', 'petx']",https://twitter.com/bradloncar/status/759786548309000192,False,,0,,,,,,,,[],,,,
739476870132011008,739476870132011008,2016-06-05 20:49:59 IST,2016-06-05,20:49:59,+0530,274233761,bradloncar,Brad Loncar,,$EXEL Cabo - more secondary endpoint analysis from METEOR.  https://t.co/WSm1aUY9QQ,en,[],[],"['https://pbs.twimg.com/media/CkMmRkiXEAQYSwf.jpg', 'https://pbs.twimg.com/media/CkMmRmSWgAAUdiR.jpg', 'https://pbs.twimg.com/media/CkMmRn0XAAA3wng.jpg']",0,0,8,[],['exel'],https://twitter.com/bradloncar/status/739476870132011008,False,,1,https://pbs.twimg.com/media/CkMmRkiXEAQYSwf.jpg,,,,,,,[],,,,
739476112154185728,739476112154185728,2016-06-05 20:46:58 IST,2016-06-05,20:46:58,+0530,274233761,bradloncar,Brad Loncar,,$EXEL Cabo - this is the OS data from METEOR. #ASCO16  https://t.co/3MCWPbrF64,en,[],[],['https://pbs.twimg.com/media/CkMlmsKWgAA9WOA.jpg'],1,8,9,['asco16'],['exel'],https://twitter.com/bradloncar/status/739476112154185728,False,,1,https://pbs.twimg.com/media/CkMlmsKWgAA9WOA.jpg,,,,,,,[],,,,
724993803443122176,724993803443122176,2016-04-26 21:39:27 IST,2016-04-26,21:39:27,+0530,11247222,timothysykes,Timothy Sykes,"{'type': 'Point', 'coordinates': [40.70638889, -74.00944444]}","Another great morning for  https://t.co/M7k2isygSF subscribers, $SEED $EXEL $AMD $UNXL‚Ä¶  https://t.co/UW87AYuwUX",en,[],"['http://timothysykes.com/plans', 'https://www.instagram.com/p/BEq232pDVi6/']",[],1,6,19,[],"['seed', 'exel', 'amd']",https://twitter.com/timothysykes/status/724993803443122176,False,,0,,,,,,,,[],,,,
724914697707884544,724914697707884544,2016-04-26 16:25:06 IST,2016-04-26,16:25:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Congrats to $EXEL on Cabometyx approval. Good label w/ OS benefit. Price: $165,000 per yr. &gt; than Afinitor/Inlyta. Watch launch vs. Opdivo.",en,[],[],[],2,10,22,[],['exel'],https://twitter.com/adamfeuerstein/status/724914697707884544,False,,0,,,,,,,,[],,,,
694143985804247040,694143985804247040,2016-02-01 18:33:17 IST,2016-02-01,18:33:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$EXEL Kidney Cancer Survival Benefit Doesn't Address Competitive Question ‚Äî&gt;  https://t.co/i7PIUbdSvQ $BMY Opdivo looms large.,en,[],['http://www.thestreet.com/story/13442006/1/exelixis-kidney-cancer-survival-benefit-doesn-t-address-competitive-question.html'],[],2,4,8,[],"['exel', 'bmy']",https://twitter.com/adamfeuerstein/status/694143985804247040,False,,0,,,,,,,,[],,,,
678872556468858881,678872556468858881,2015-12-21 15:10:04 IST,2015-12-21,15:10:04,+0530,873399943,jacobplieth,Jacob Plieth,,$MRK goes one up on $BMY in 1L melanoma. What does this mean for Braf/Mek inhibitors? $NVS $EXEL $RHHBY $ARRY  https://t.co/DK5Jkk5WuM,en,[],[],['https://pbs.twimg.com/media/CWvW_gzWcAASh_M.jpg'],3,5,11,[],"['mrk', 'bmy', 'nvs', 'exel', 'rhhby', 'arry']",https://twitter.com/JacobPlieth/status/678872556468858881,False,,1,https://pbs.twimg.com/media/CWvW_gzWcAASh_M.jpg,,,,,,,[],,,,
664109351687221249,664109351687221249,2015-11-10 21:26:22 IST,2015-11-10,21:26:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$EXEL $RHHBY - FDA approves cobimetinib in use with vemurafinib  to treat melanoma.   FDA PR ‚Äî&gt;  https://t.co/rGKSYK3Of9,en,[],['http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471934.htm'],[],0,11,5,[],"['exel', 'rhhby']",https://twitter.com/adamfeuerstein/status/664109351687221249,False,,0,,,,,,,,[],,,,
652232453407510529,652232453407510529,2015-10-09 02:51:49 IST,2015-10-09,02:51:49,+0530,47678782,megtirrell,Meg Tirrell,,He's been called the godfather of biotech. Tune in to @CNBCFastMoney tonight for our chat w $BIIB $EXEL $RGLS Chairman Stelios Papadopoulos,en,"[{'screen_name': 'cnbcfastmoney', 'name': ""cnbc's fast money"", 'id': '16732770'}]",[],[],0,6,8,[],"['biib', 'exel', 'rgls']",https://twitter.com/megtirrell/status/652232453407510529,False,,0,,,,,,,,[],,,,
651263042911494144,651263042911494144,2015-10-06 10:39:43 IST,2015-10-06,10:39:43,+0530,274233761,bradloncar,Brad Loncar,,$EXEL coBRIM hit OS.  http://t.co/WNuOxePviQ,ca,[],['http://www.businesswire.com/news/home/20151005006803/en/'],[],2,4,6,[],['exel'],https://twitter.com/bradloncar/status/651263042911494144,False,,0,,,,,,,,[],,,,
647542857851662336,647542857851662336,2015-09-26 04:17:02 IST,2015-09-26,04:17:02,+0530,47678782,megtirrell,Meg Tirrell,,$EXEL up 22% after hrs on kidney cancer data:  http://t.co/0C4lYhENSU,en,[],['http://www.exelixis.com/investors-media/press-releases?cpurl=http%3A%2F%2Fir.exelixis.com/phoenix.zhtml?c=120923%26p=irol-newsArticle%26ID=2090565%26highlight='],[],1,13,15,[],['exel'],https://twitter.com/megtirrell/status/647542857851662336,False,,0,,,,,,,,[],,,,
647533082606702592,647533082606702592,2015-09-26 03:38:12 IST,2015-09-26,03:38:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMY $EXEL Drugs Demonstrate Treatment Benefit in Kidney Cancer  http://t.co/cNGgmTTzK0 via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13302067/1/bristol-exelixis-drugs-demonstrate-treatment-benefit-in-kidney-cancer.html'],[],1,24,25,[],"['bmy', 'exel']",https://twitter.com/adamfeuerstein/status/647533082606702592,False,,0,,,,,,,,[],,,,
647532830445162496,647532830445162496,2015-09-26 03:37:12 IST,2015-09-26,03:37:12,+0530,873399943,jacobplieth,Jacob Plieth,,"Cometriq plays wallflower as Opdivo‚Äôs dance card fills, from @ByJonGardner #ECC2015  http://t.co/eaFqDomEbi $EXEL $BMY",en,"[{'screen_name': 'byjongardner', 'name': 'jon gardner', 'id': '960747870'}]",['http://ow.ly/SGpFm'],[],3,10,11,['ecc2015'],"['exel', 'bmy']",https://twitter.com/JacobPlieth/status/647532830445162496,False,,0,,,,,,,,[],,,,
647480342560043008,647480342560043008,2015-09-26 00:08:37 IST,2015-09-26,00:08:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"While you‚Äôre drowning biotech sorrows w/ that 5th or 6th beer tonight, you‚Äôll be able to read my $BMY $EXEL kidney cancer ph3 data story!",en,[],[],[],5,2,9,[],"['bmy', 'exel']",https://twitter.com/adamfeuerstein/status/647480342560043008,False,,0,,,,,,,,[],,,,
644850424642707456,644850424642707456,2015-09-18 17:58:16 IST,2015-09-18,17:58:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech Stock Mailbag: $BMY vs. $EXEL next week, What happened $LBIO?  $GWPH is Lake Wobegon $RMTI $GNFTF trolling   http://t.co/MZAqNq5jum",en,[],['http://www.thestreet.com/story/13292795/1/biotech-stock-mailbag-bristol-exelixis-lion-bio-gw-pharma.html'],[],2,13,12,[],"['bmy', 'exel', 'lbio', 'gwph', 'rmti', 'gnftf']",https://twitter.com/adamfeuerstein/status/644850424642707456,False,,0,,,,,,,,[],,,,
623423992645468160,623423992645468160,2015-07-21 14:57:17 IST,2015-07-21,14:57:17,+0530,873399943,jacobplieth,Jacob Plieth,,$NVS Afinitor slide. Looks like RCC sales are already flat at best. $BMY $EXEL  http://t.co/aoCNVotUfc,en,[],[],['https://pbs.twimg.com/media/CKbY0UvWgAAWSf8.jpg'],0,3,3,[],"['nvs', 'bmy', 'exel']",https://twitter.com/JacobPlieth/status/623423992645468160,False,,1,https://pbs.twimg.com/media/CKbY0UvWgAAWSf8.jpg,,,,,,,[],,,,
623105541225750528,623105541225750528,2015-07-20 17:51:52 IST,2015-07-20,17:51:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Fun fact: $BMY once had development rights to cabozantinib (Cometriq), returned drug to $EXEL in 2011. Can't make this stuff up.",en,[],[],[],1,1,5,[],"['bmy', 'exel']",https://twitter.com/adamfeuerstein/status/623105541225750528,False,,0,,,,,,,,[],,,,
623103149784629248,623103149784629248,2015-07-20 17:42:22 IST,2015-07-20,17:42:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$EXEL gets about an hour to savor Cometriq kidney cancer victory and then... $BMY drops an Opdivo bomb on the party. Unreal.,en,[],[],[],4,9,14,[],"['exel', 'bmy']",https://twitter.com/adamfeuerstein/status/623103149784629248,False,,0,,,,,,,,[],,,,
623086017420107776,623086017420107776,2015-07-20 16:34:17 IST,2015-07-20,16:34:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$EXEL Scores Much-Needed Kidney Cancer Study to Boost Drug Sales  http://t.co/GQPBnKstFD via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13223186/1/exelixis-scores-much-needed-kidney-cancer-study-to-boost-drug-sales.html'],[],1,19,13,[],['exel'],https://twitter.com/adamfeuerstein/status/623086017420107776,False,,0,,,,,,,,[],,,,
614398311806697472,614398311806697472,2015-06-26 17:12:27 IST,2015-06-26,17:12:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech Stock Mailbag: $EXEL kidney cancer data coming soon, plus what's next for $PBYI --&gt;  http://t.co/cp5sAuew3n via @TheStreet",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13199783/1/biotech-stock-mailbag-exelixis-puma-bio.html'],[],1,9,13,[],"['exel', 'pbyi']",https://twitter.com/adamfeuerstein/status/614398311806697472,False,,0,,,,,,,,[],,,,
561026052793720832,561026052793720832,2015-01-30 10:30:09 IST,2015-01-30,10:30:09,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,ENORMOUS Call Option Accumulator in $EXEL (Micro Cap Biotech) data via --&gt;  http://t.co/u4N6fcKpqK  http://t.co/seO1FdXTOM,fr,[],['http://bit.ly/lv_orderflow'],['https://pbs.twimg.com/media/B8kE6FDCEAAHSXF.png'],1,6,15,[],['exel'],https://twitter.com/OphirGottlieb/status/561026052793720832,False,,1,https://pbs.twimg.com/media/B8kE6FDCEAAHSXF.png,,,,,,,[],,,,
506568570697162752,506568570697162752,2014-09-02 03:55:33 IST,2014-09-02,03:55:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"""In 2014, I'm confident Exelixis performs better than Ariad.‚Äù   http://t.co/8DaMFDyKkO Wrong. $EXEL $ARIA",en,[],['http://www.thestreet.com/story/12201246/2/biotech-stock-mailbag-inovio-chelsea-exelixis-ariad-immunocellular.html'],[],3,4,10,[],"['exel', 'aria']",https://twitter.com/adamfeuerstein/status/506568570697162752,False,,0,,,,,,,,[],,,,
488704227191955456,488704227191955456,2014-07-14 20:49:02 IST,2014-07-14,20:49:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I spoke with @AlpineBV_Miller about why he believes $RHHBY will buy $EXEL ‚Äî&gt;  http://t.co/HN57XqCadJ,en,"[{'screen_name': 'alpinebv_miller', 'name': 'david miller', 'id': '1711239283'}]",['http://www.thestreet.com/story/12772905/1/investor-believes-roche-buys-exelixis-for-skin-cancer-drug.html'],[],4,14,11,[],"['rhhby', 'exel']",https://twitter.com/adamfeuerstein/status/488704227191955456,False,,0,,,,,,,,[],,,,
423577557389152256,423577557389152256,2014-01-16 03:38:54 IST,2014-01-16,03:38:54,+0530,274233761,bradloncar,Brad Loncar,,Here's a summary of the five ongoing cabozantinib pivotal trials. $EXEL #JPM14  http://t.co/vnGWKqbarX,en,[],[],['https://pbs.twimg.com/media/BeDZi0kCUAAyy1h.png'],1,7,7,['jpm14'],['exel'],https://twitter.com/bradloncar/status/423577557389152256,False,,1,https://pbs.twimg.com/media/BeDZi0kCUAAyy1h.png,,,,,,,[],,,,
419095341175029760,419095341175029760,2014-01-03 18:48:10 IST,2014-01-03,18:48:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This week‚Äôs Biotech Stock Mailbag ‚Äî&gt;  http://t.co/F9H8zwRJkA $INO $CHTP $EXEL $ARIA $IMUC,en,[],['http://www.thestreet.com/story/12201246/1/biotech-stock-mailbag-inovio-chelsea-exelixis-ariad-immunocellular.html'],[],6,7,8,[],"['ino', 'chtp', 'exel', 'aria', 'imuc']",https://twitter.com/adamfeuerstein/status/419095341175029760,False,,0,,,,,,,,[],,,,
383570954669920256,383570954669920256,2013-09-27 18:06:56 IST,2013-09-27,18:06:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This week's Biotech Stock Mailbag --&gt;  http://t.co/IO8EdQ8CN1 $CLDX $EXEL $GERN $NPSP,en,[],['http://www.thestreet.com/story/12050599/1/biotech-stock-mailbag-celldex-exelixis-geron-nps-pharma.html'],[],3,4,8,[],"['cldx', 'exel', 'gern', 'npsp']",https://twitter.com/adamfeuerstein/status/383570954669920256,False,,0,,,,,,,,[],,,,
243296128865562624,243296128865562624,2012-09-05 16:04:52 IST,2012-09-05,16:04:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Essential 2012 Biotech Fall Preview --&gt;  http://t.co/dCSNoeOQ My look at what to expect before year end. $ARIA $EXEL $CLSN $SRPT $AMRN et al,en,[],['http://bit.ly/RKkJjC'],[],3,12,7,[],"['aria', 'exel', 'clsn', 'srpt', 'amrn']",https://twitter.com/adamfeuerstein/status/243296128865562624,False,,0,,,,,,,,[],,,,
